Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Patrick Kesteven

Newcastle AuthorsTitleYearFull text
Dr Kathryn Musgrave
Dr Jonathan Scott
Dr Wezi Sendama
Aaron Gardner
Fiona Dewar
et al.		Tissue factor expression in monocyte subsets during human immunothrombosis, endotoxemia and sepsis2023
Dr Kathryn Musgrave
Jonathan Scott
Dr Wezi Sendama
Dr Patrick Kesteven
Dr Marie-Helene Ruchaud
et al.		The differential surface expression of tissue factor between monocyte subsets2020
Salah Abohelaika
Dr Hilary Wynne
Dr Peter Avery
Dr Patrick Kesteven
Professor Farhad Kamali
Impact of age on long-term anticoagulation and how gender and monitoring setting affect it: implications for decision making and patient management2016
Dr Kate Musgrave
Professor John Simpson
Dr Patrick Kesteven
Is there any clinical or biological difference that distinguishes recurrence from non-recurrence after idiopathic PE?2016
Dr Patrick Kesteven
The management of acute venous thromboembolism in clinical practice – study rationale and protocol of the European PREFER in VTE Registry2015
Salah Abohelaika
Professor Farhad Kamali
Dr Peter Avery
Dr Patrick Kesteven
Dr Hilary Wynne
Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England2014
Basav Sen
Dr Patrick Kesteven
Dr Peter Avery
Comparison of D-dimer point of care test (POCT) against current laboratory test in patients with suspected venous thromboembolism (VTE) presenting to the emergency department (ED)2014
Dr Patrick Kesteven
Professor Ann Daly
Dr Peter Avery
Professor Farhad Kamali
A Randomized Trial Comparing Genotype-Guided Dosing of Warfarin to Standard Dosing: The EU Pharmacogenetics of Anticoagulant Therapy (EU-PACT) Warfarin Study2013
Dr Patrick Kesteven
Julian Leathart
Professor Ann Daly
Professor Farhad Kamali
A Randomized Trial of Genotype-Guided Dosing of Warfarin2013
Professor Farhad Kamali
Dr Hilary Wynne
Dr Patrick Kesteven
Dr John Hanley
Dr Jing Shen
et al.		Improving the safety and efficacy of anticoagulation therapy for thromboembolic disease through Vitamin K2013
Dr Logan Thirugnanasothy
Dr Patrick Kesteven
Professor John Dark
Pulmonary embolism: Surgical embolectomy is underused2013
Dr Arun Natarajan
Emerita Professor Sally Marshall
Dr Patrick Kesteven
Dr Janet McComb
Impact of biomarkers for endothelial dysfunction and procoagulant state on 10-year cardiovascular risk in Type 2 diabetes2011
Mohamed Noormohamed
Susan Stamp
Dr Brian Shenton
Dr Patrick Kesteven
Dr Noel Carter
et al.		Effects of extra corporeal membrane oxygenation (ECMO) on liver function and histology, in a porcine model of uncontrolled non heart beating donor (NHBD)2010
Dr Montserrat Briz Del Blanco
Dr Katherine Talks
Dr John Hanley
Dr Patrick Kesteven
Professor Ann Daly
et al.		Reversal of warfarin-induced over-anticoagulation with individualized dosing of oral vitamin K: a pilot study2010
Dr Katherine Talks
Dr John Hanley
Dr Patrick Kesteven
Dr Peter Avery
Professor Ann Daly
et al.		Individualised oral vitamin K for reversal of warfarin excessive anticoagulation2009
1234